Results 141 to 150 of about 5,870,697 (401)

Physicians’ understanding of antibiotic intravenous-to-oral switching—a qualitative study in Suzhou, China

open access: yesBMC Health Services Research
Background The implementation of antibiotic intravenous-to-oral switch (IVOS) therapy in hospitals can slow down the development of drug resistance, reduce the occurrence of adverse reactions, and bring significant economic benefits.
Hui Zhang   +4 more
doaj   +1 more source

Механізми стійкості до антибіотиків представників родини Enterobacteriaceae

open access: yesRegulatory Mechanisms in Biosystems, 2014
Наведено характеристику ентеробактерій та показано їх роль у патології людини. Проаналізовано відомості про головні напрями антибіотикотерапії уражень, зумовлених представниками родини Enterobacteriaceae, подано матеріали про проблеми антибіотикотерапії,
K. R. Kotsyuba   +3 more
doaj   +1 more source

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

open access: yesExpert Review of Anti-Infective Therapy, 2019
Introduction: Anti-Microbial Resistance (AMR) is a pandemic which threatens modern medicine. There is a lack of effective drug treatment due to the slow pace, high cost and low achievable sales prices of new antibiotic monotherapies.
A. Coates, Yanmin Hu, James Holt, P. Yeh
semanticscholar   +1 more source

Two‐Dimensional Materials as a Multiproperty Sensing Platform

open access: yesAdvanced Functional Materials, EarlyView.
Various sensing modalities enabled and/or enhanced by two‐dimensional (2D) materials are reviewed. The domains considered for sensing include: 1) optoelectronics, 2) quantum defects, 3) scanning probe microscopy, 4) nanomechanics, and 5) bio‐ and chemosensing.
Dipankar Jana   +11 more
wiley   +1 more source

АНТИБИОТИК-АССОЦИИРОВАННАЯ ДИАРЕЯ: АКТУАЛЬНОСТЬ ПРОБЛЕМЫ, ПРОФИЛАКТИКА И ТЕРАПИЯ

open access: yesАрхивъ внутренней медицины, 2013
The problem of antibiotic-associated conditions is one of the most actual problems of clinical practice. The antibiotic-associated diarrhea is a multidisciplinary problem. Prevention and therapy an antibiotic-associated diarrhea should include probiotics
Ю. П. Успенский   +1 more
doaj   +1 more source

Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study

open access: yesBMC Infectious Diseases, 2016
BackgroundCommunity-acquired bacterial meningitis (CABM) is a life-threatening disease and timing of antibiotic therapy remains crucial. We aimed to analyse the impact of antibiotic timing on the outcome of CABM in a contemporary cohort.MethodsWe ...
J. Bodilsen   +3 more
semanticscholar   +1 more source

Programmable DNA‐Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes

open access: yesAdvanced Functional Materials, EarlyView.
A multivalent antiviral platform based on honeycomb‐shaped DNA nanostructures (HC–Urumin) is developed to enhance the potency and breadth of the host defense peptide Urumin. Through spatially patterned trimeric presentation, HC–Urumin disrupts influenza A virus entry, improves cell viability, and reduces disease severity in vivo‐offering a modular and ...
Saurabh Umrao   +11 more
wiley   +1 more source

DAIR in treating late-phase infection after total knee arthroplasty using continuous local antibiotic perfusion therapy: A case series study [PDF]

open access: green, 2023
Yukichi Zenke   +10 more
openalex   +1 more source

Upconversion Nanoparticles Embedded Photonic Contact Lens for Transepithelial Corneal Crosslinking Using Hyaluronate – Riboflavin Conjugate

open access: yesAdvanced Functional Materials, EarlyView.
A minimally invasive, transepithelial corneal cross‐linking (TE‐CXL) approach is presented using upconversion nanoparticles (UCNPs)‐loaded contact lenses (UCLs), after topical delivery of hyaluronate–riboflavin conjugates. The NIR‐to‐UV/blue light conversion by UCNPs in a UCL can activate riboflavin for TE‐CXL, resulting in the biomechanical strength ...
Gibum Lee   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy